DE3129309A1 - Hypoglykaemische 5-substituierte oxazolidin-2,4-dione - Google Patents

Hypoglykaemische 5-substituierte oxazolidin-2,4-dione

Info

Publication number
DE3129309A1
DE3129309A1 DE19813129309 DE3129309A DE3129309A1 DE 3129309 A1 DE3129309 A1 DE 3129309A1 DE 19813129309 DE19813129309 DE 19813129309 DE 3129309 A DE3129309 A DE 3129309A DE 3129309 A1 DE3129309 A1 DE 3129309A1
Authority
DE
Germany
Prior art keywords
dione
oxazolidine
chloro
mol
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19813129309
Other languages
German (de)
English (en)
Other versions
DE3129309C2 (enExample
Inventor
Rodney Caughren New London Conn. Schnur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE3129309A1 publication Critical patent/DE3129309A1/de
Application granted granted Critical
Publication of DE3129309C2 publication Critical patent/DE3129309C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/44—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/008—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with tri- or tetrahalomethyl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/546—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/55—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/62—Barbituric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/46—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19813129309 1980-07-28 1981-07-24 Hypoglykaemische 5-substituierte oxazolidin-2,4-dione Granted DE3129309A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17320680A 1980-07-28 1980-07-28
US06/222,202 US4367234A (en) 1980-07-28 1981-01-02 Hypoglycemic 5-substituted oxazolidine-2,4-diones

Publications (2)

Publication Number Publication Date
DE3129309A1 true DE3129309A1 (de) 1982-03-18
DE3129309C2 DE3129309C2 (enExample) 1987-06-19

Family

ID=26868872

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19813129309 Granted DE3129309A1 (de) 1980-07-28 1981-07-24 Hypoglykaemische 5-substituierte oxazolidin-2,4-dione

Country Status (27)

Country Link
US (1) US4367234A (enExample)
KR (3) KR850000381B1 (enExample)
AR (3) AR228061A1 (enExample)
AT (1) AT376424B (enExample)
AU (1) AU526905B2 (enExample)
CA (1) CA1155855A (enExample)
CH (1) CH653025A5 (enExample)
DD (1) DD202149A5 (enExample)
DE (1) DE3129309A1 (enExample)
DK (1) DK151882C (enExample)
ES (3) ES8306367A1 (enExample)
FI (1) FI77457C (enExample)
FR (1) FR2487348B1 (enExample)
GB (3) GB2083810B (enExample)
GR (1) GR74590B (enExample)
HU (1) HU185682B (enExample)
IE (1) IE51427B1 (enExample)
IL (1) IL63422A (enExample)
IT (1) IT1138110B (enExample)
LU (1) LU83512A1 (enExample)
NL (1) NL8103536A (enExample)
NO (1) NO812558L (enExample)
NZ (1) NZ197853A (enExample)
PH (1) PH17421A (enExample)
PT (1) PT73437B (enExample)
SE (1) SE460849B (enExample)
YU (3) YU185281A (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689336A (en) * 1981-01-02 1987-08-25 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine 2,4-diones
GR78120B (enExample) * 1982-03-01 1984-09-26 Pfizer
US4430337A (en) * 1982-06-23 1984-02-07 Pfizer Inc. Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity
JPS59186916A (ja) * 1983-04-06 1984-10-23 Aiji Noda 膵石症治療剤
US5130379A (en) * 1988-03-08 1992-07-14 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
US4946942A (en) * 1988-03-11 1990-08-07 Bioresearch, Inc. Urethane-protected amino acid-N-carboxyanhydrides
US5442124A (en) * 1989-06-30 1995-08-15 Firmenich Sa Process for the preparation of novel aromatic compounds
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
US5036079A (en) * 1989-12-07 1991-07-30 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
CZ288351B6 (en) * 1990-06-07 2001-05-16 Astrazeneca Ab Nitrogenous heterocyclic compound, process of its preparation and use as well as a medicament containing thereof
GB9017218D0 (en) * 1990-08-06 1990-09-19 Beecham Group Plc Novel compounds
FI930772L (fi) * 1990-08-23 1993-02-22 Pfizer Hydroxiureaderivat som saenker glugosnivao i blodet
TW222626B (enExample) 1991-07-22 1994-04-21 Pfizer
US5498621A (en) * 1992-05-01 1996-03-12 Pfizer Inc. Oxazolidinedione hypoglycemic agents
US5401761A (en) * 1993-12-09 1995-03-28 Pfizer, Inc. Thiazolidinedione hypoglycemic agents
US5925656A (en) * 1995-04-10 1999-07-20 Dr. Reddy's Research Foundation Compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
GB9604242D0 (en) 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
ZA973848B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
ZA973850B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel antidiabetic compounds having hypolipidaemic, anti-hypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6114526A (en) * 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
AU744518B2 (en) 1996-07-01 2002-02-28 Dr. Reddy's Laboratories Limited Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6372750B2 (en) * 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
IL141456A0 (en) * 1998-08-21 2002-03-10 Viropharma Inc Rhodanine derivatives and pharmaceutical compositions containing the same
AU6331199A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Oxazolidine derivatives for the treatment and prevention of metabolic bone disorders
EP1194146B1 (en) 1999-06-18 2006-07-19 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
US6380191B1 (en) 1999-06-18 2002-04-30 Merck & Co. Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
TW200901959A (en) 2007-03-09 2009-01-16 Indigene Pharmaceuticals Inc Combination of metformin R-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications
JP5417860B2 (ja) * 2008-08-26 2014-02-19 住友化学株式会社 α−ヒドロキシエステル類の製造方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE108026A (enExample)
DE729852C (de) * 1939-07-06 1943-01-04 Carl Nachtigall Verfahren zur Herstellung von 2, 4-Dioxooxazolidinen
US2721197A (en) * 1953-01-05 1955-10-18 Bristol Lab Inc Bicyclic lactams
US2961377A (en) * 1957-08-05 1960-11-22 Us Vitamin Pharm Corp Oral anti-diabetic compositions and methods
US3699229A (en) * 1970-12-18 1972-10-17 Abbott Lab 2-oxo-5-phenyl-4-oxazolidinone as an anti-depressant agent
DD108026A5 (de) * 1972-11-06 1974-09-05 Karl F Rath Verfahren und vorrichtung zum einsetzen von pflanzen
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4220787A (en) * 1978-03-31 1980-09-02 Basf Aktiengesellschaft Preparation of oxazolidine-2,4-diones

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2338220A (en) * 1942-01-31 1944-01-04 Mallinckrodt Chemical Works Process of making oxazolidinediones
FR1284516A (fr) * 1957-11-20 1962-02-16 France Etat Produits utilisables notamment comme agents susceptibles d'agir sur la croissance des plantes et leur procédé de fabrication
GB1227428A (enExample) * 1968-04-08 1971-04-07
FR2207706B1 (enExample) * 1972-11-24 1975-11-28 Orsymonde

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE108026A (enExample)
DE729852C (de) * 1939-07-06 1943-01-04 Carl Nachtigall Verfahren zur Herstellung von 2, 4-Dioxooxazolidinen
US2721197A (en) * 1953-01-05 1955-10-18 Bristol Lab Inc Bicyclic lactams
US2961377A (en) * 1957-08-05 1960-11-22 Us Vitamin Pharm Corp Oral anti-diabetic compositions and methods
US3699229A (en) * 1970-12-18 1972-10-17 Abbott Lab 2-oxo-5-phenyl-4-oxazolidinone as an anti-depressant agent
DD108026A5 (de) * 1972-11-06 1974-09-05 Karl F Rath Verfahren und vorrichtung zum einsetzen von pflanzen
US4220787A (en) * 1978-03-31 1980-09-02 Basf Aktiengesellschaft Preparation of oxazolidine-2,4-diones
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones

Non-Patent Citations (18)

* Cited by examiner, † Cited by third party
Title
Archiv Pharm, 313, 1980, S. 229-237, 817-825 *
Bull.Soc.chim., Frankreich 1961, S. 1226-1230 *
Burger's Medicinal Chemistry, 4. Aufl., Teil II, S. 1057-1080, N.Y. 1979 *
Chem.Ber., Bd. 19,1886,S. 1708-1714 *
Chemical Abstracts, Vol. 79, 1973, 62276g, Vol. 78, 1973, 38125z *
Chemical Reviews, 58, 1958,S. 63-99 *
Die Pharmazie, Bd. 20, 1965, S. 115 *
Ehrhart, G.- Ruschig, H.: Arzneimittel, Bd. 3, 1972, S. 285, 288 *
Forth, W. - Henschler, D. - Rummel, W.: Pharmakologie und Toxikologie, 2. Aufl., 1977, S. 295, 300, 301
Gazz.chim.ital., 16, 1886, S. 357 *
J.Amer.Chem.Soc., Vol. 61, 1939, S. 3491-3493 *
J.Amer.Chem.Soc., Vol. 81, 1959, S. 3083-3088, 5646-5650, 6498-6504 *
J.Chem.Soc., 1951, S. 3077-3079 *
Journal Neuro. Chem., 19, 7, 1972, S. 1783-1788 *
Maske,H.: Oral wirksame Antidiabetika,Bd. XXIX der Reihe Handbuch der experimentellen Pharmakologie, 1971, S. 6 *
Münch.med.Wochenschrift, 117, 1975, S. 1221-1228 *
Rote Liste, 1986, 11040-11073 *
Ullmann: Encyclopädie der technischen Chemie, Bd. 18, 1979,S. 126,128 *

Also Published As

Publication number Publication date
NO812558L (no) 1982-01-29
ES8306132A1 (es) 1983-05-01
HU185682B (en) 1985-03-28
GB2083810A (en) 1982-03-31
ES8306133A1 (es) 1983-05-01
YU185281A (en) 1983-12-31
IT8123175A0 (it) 1981-07-27
IL63422A (en) 1984-11-30
NL8103536A (nl) 1982-02-16
NZ197853A (en) 1986-09-10
AR228061A1 (es) 1983-01-14
FI77457B (fi) 1988-11-30
GB2083810B (en) 1984-03-14
KR850000381B1 (ko) 1985-03-23
KR850000382B1 (ko) 1985-03-23
US4367234A (en) 1983-01-04
YU88183A (en) 1983-12-31
SE8104542L (sv) 1982-01-29
CH653025A5 (fr) 1985-12-13
DE3129309C2 (enExample) 1987-06-19
FR2487348A1 (fr) 1982-01-29
KR850003290A (ko) 1985-06-13
ES514665A0 (es) 1983-05-01
GB8317144D0 (en) 1983-07-27
DK151882C (da) 1988-06-06
ES504322A0 (es) 1983-05-16
CA1155855A (en) 1983-10-25
GB2132609A (en) 1984-07-11
GB2128987A (en) 1984-05-10
KR850003291A (ko) 1985-06-13
AR231721A1 (es) 1985-02-28
DK334681A (da) 1982-03-05
GB8317145D0 (en) 1983-07-27
GB2132609B (en) 1985-01-03
AU526905B2 (en) 1983-02-03
AR230834A1 (es) 1984-07-31
FI77457C (fi) 1989-03-10
PH17421A (en) 1984-08-08
GB2128987B (en) 1984-09-26
ES514666A0 (es) 1983-05-01
IE811695L (en) 1982-01-28
FI812340L (fi) 1982-01-29
LU83512A1 (fr) 1982-02-17
KR830006247A (ko) 1983-09-20
IL63422A0 (en) 1981-10-30
PT73437B (en) 1983-09-01
SE460849B (sv) 1989-11-27
IT1138110B (it) 1986-09-17
ES8306367A1 (es) 1983-05-16
GR74590B (enExample) 1984-06-29
PT73437A (en) 1981-08-01
DD202149A5 (de) 1983-08-31
ATA328681A (de) 1984-04-15
YU88283A (en) 1983-12-31
DK151882B (da) 1988-01-11
IE51427B1 (en) 1986-12-24
AT376424B (de) 1984-11-26
FR2487348B1 (fr) 1986-05-02
KR850000387B1 (ko) 1985-03-25

Similar Documents

Publication Publication Date Title
DD202149A5 (de) Verfahren zur herstellung von 5-substituierten oxazolidin-2,4-dionen
DE69015587T2 (de) Hypoglykämische Oxazolidindion-Derivate.
US4110337A (en) Triazolobenzodiazepines
DE3875073T2 (de) 3-(4(1-substituierte-4-piperazinyl)butyl)-4-thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel.
DE3876813T4 (de) 3(2H)Pyridazinon, Verfahren zu dessen Herstellung und dieses enthaltendes Mittel gegen SRS-A.
DE2165962A1 (de) 4-Hydroxy-6-arylpyrimidine. Ausscheidung aus: 2149249
DE69107959T2 (de) 3-Cycloalkylpropansäureamide, ihre Tautomere und Salze, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel und sie enthaltende Zusammensetzungen.
DE3874358T2 (de) 4-(3h)-chinazolinon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen.
EP0041215B1 (de) Imidazoazolalkensäureamide, neue Zwischenprodukte zu ihrer Herstellung, ihre Herstellung und ihre Verwendung in Arzneimitteln
EP0183159A2 (de) 1-Heteroaryl-4-aryl-pyrazolin-5-one zur Verwendung als Arzneimittel
DE69222459T2 (de) Thiazolidindionderivate, ihre Herstellung und Anwendung
EP1098891B1 (de) Polycyclische thiazolidin-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0185909B1 (de) 5-Alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2648826A1 (de) Triazolderivate
EP0171739B1 (en) Imidazo[1,5-a]pyrimidine derivatives and process for their preparation
DD202555A5 (de) Hypoglykaemische 5-substituierte oxazolidin-2,4-dione
DE60211149T2 (de) Pyrimidinderivate zur verwendung als selektive cox-2 inhibitoren
US4282242A (en) Antidiabetic pyrrolecarboxylic acids
DE69026087T2 (de) Substituierte 2-imidazoline und verfahren zur herstellung sowie deren verwendung
DE69410021T2 (de) N-Phenyl-2-Cyano-3-hydroxypropenamide, ihre Tautomeren, ihre Salze, Verfahren zu ihrer Herstellung, ihre Anwendung als Medikamente und Zusammensetzungen, die sie enthalten
DE3020421A1 (de) Imidazoazolalkensaeureamide, neue zwischenprodukte zu ihrer herstellung, ihre herstellung und ihre verwendung in arzneimitteln
US4351843A (en) Antidiabetic pyrrolecarboxylic acids
DD201594A5 (de) Verfahren zur herstellung von neuen polyazaheterocyclischen verbindungen
DE2501833A1 (de) 4'-chlor-4-aethinylbiphenyl, verfahren zur herstellung dieser verbindung und diese verbindung enthaltende mittel
DE69805596T2 (de) Imidazol-Derivat und dieses als aktiven Bestandteil enthaltendes Arzneimittel

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee